E

CurveBeam AI Limited CRVAF

$0.05 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Day's Range
$0.05$0.05
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

CRVAF Rating

Reward
Risk

CRVAF Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

CRVAF Company Overview

CurveBeam AI Limited is a medical technology company focused on orthopedic imaging systems and artificial intelligence-enabled diagnostic software. The company operates in the healthcare technology and medical imaging industries, with a primary emphasis on weight-bearing computed tomography (WBCT) systems used in orthopedic and musculoskeletal assessment. Its products are designed to provide three-dimensional imaging of the lower extremities, including feet, ankles, knees, and hips, while patients are standing in natural load-bearing positions. The company’s revenue drivers include imaging hardware sales, software licensing, service agreements, and related clinical support offerings.

The company evolved through the combination of advanced imaging technologies and AI-enabled analytics intended to improve orthopedic diagnosis and surgical planning. CurveBeam AI has positioned itself within a specialized segment of musculoskeletal imaging by focusing on low-dose cone beam CT systems tailored for orthopedic use rather than broad general radiology applications. Its strategic positioning is supported by relationships with orthopedic clinics, hospitals, imaging centers, and research institutions seeking specialized imaging capabilities for sports medicine, deformity assessment, and pre-operative planning.

Data compiled by narrative technology. May contain errors.
Sector

CRVAF Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

CRVAF Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

CRVAF Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

CRVAF Price History

Loading...
52-Week RangeRange unavailable
Current
$0.05
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--

CRVAF Valuation

Market Cap
Market Cap Rank
#14,489
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

CRVAF Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

CRVAF Corporate Info

Phone Number
267 483 8081
Address
2800 Bronze Drive
Suite 110
Hatfield, PA 19440
Country
Year Founded

CRVAF Filings

Filing Date
Sunday, August 30, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

CRVAF Headlines

There are no news to display.